Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombosis Prophylaxis with Implantable Devices in Cancer Patients
NCT00199602Phase 3Completed
- Sponsor
- CHU de Limoges
- Start
- Aug 1999
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of warfarin, low molecular weight heparin calcium in deep vein thrombosis (DVT), sponsored by CHU de Limoges. Started Aug 1999; status: completed.
02
Drugs
warfarinlow molecular weight heparin calcium
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00199602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199602.